| Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer MP Petrova, MI Eneva, JI Arabadjiev, NV Conev, EG Dimitrova, ... Bioscience trends 14 (1), 48-55, 2020 | 55 | 2020 |
| Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer MP Petrova, IS Donev, MA Radanova, MI Eneva, EG Dimitrova, ... Clinical & Experimental Immunology 202 (3), 353-362, 2020 | 37 | 2020 |
| RIPK3 expression as a potential predictive and prognostic marker in metastatic colon cancer NV Conev, YK Kashlov, EG Dimitrova, YK Kashlov, MK Bogdanova, ... Clinical and Investigative Medicine 42 (1), E31-E38, 2019 | 31 | 2019 |
| Association between serum CK-18 levels and the degree of liver damage in fructose-induced metabolic syndrome K Bratoeva, S Nikolova, A Merdzhanova, GS Stoyanov, E Dimitrova, ... Metabolic syndrome and related disorders 16 (7), 350-357, 2018 | 20 | 2018 |
| 1698P The presence of COVID-19 makes more cancer patients distressed and time perception may distinguish them NV Conev, M Petrova, E Dimitrova, K Zhelev, ZI Zahariev, K Nikolov, ... Annals of Oncology 31, S1002, 2020 | 4 | 2020 |
| KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer M Radanova, G Mihaylova, GS Stoyanov, V Draganova, A Zlatarov, ... International Journal of Molecular Sciences 24 (16), 12753, 2023 | 3 | 2023 |
| Role of the pretreatment 18F-fluorodeoxyglucose positron emission tomography maximal standardized uptake value in predicting outcomes of colon liver metastases and that value's … EG Dimitrova, BG Chaushev, NV Conev, JK Kashlov, AK Zlatarov, ... Bioscience trends 11 (2), 221-228, 2017 | 3 | 2017 |
| Time perception as a novel ultra-short screening tool for distress in cancer patients. NV Conev, I Donev, D Stoyanov, M Ivanova, E Dimitrova, A Yanchev Journal of Clinical Oncology 36 (15_suppl), e22123-e22123, 2018 | 2 | 2018 |
| Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies G Todorov, C Bachvarov, G Valchev, N Kolev, A Tonev, V Ignatov, ... Varna Medical Forum 7 (1), 11-14, 2018 | 1 | 2018 |
| Embolization of bronchial arteries in cases of life-threatening bleeding G Todorov, C Bachvarov, G Valchev, R Popova, A Antonov, S Sirakov, ... Heart-Lung (Varna) 21 (1-2), 45-49, 2015 | 1 | 2015 |
| Sensory profiling of dairy starch dessert creams enhanced with various types and concentrations of tahini M Dzhivoderova-Zarcheva, K Nikovska, S Ivanova, E Dimitrova International Journal of Gastronomy and Food Science 36, 100925, 2024 | | 2024 |
| Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first‐line setting R Gencheva, M Petrova, P Kraleva, S Hadjidekova, M Radanova, ... Cancer Reports 7 (2), e1966, 2024 | | 2024 |
| 68 A pictorial view on false positive findings of Ga-PSMA-11 PET/CT and their prognostic value in patients with prostate carcinoma after radical prostatectomy and undetectable … MD Borislav Chaushev, R Marinov, V Nikolov, MD Georgi Todorov, ... Hellenic Journal of Nuclear Medicine, 2024 | | 2024 |
| Patient resilience and distress level prior to chemotherapy based on time estimation. P Kraleva, M Petrova, T Popov, NV Conev, E Dimitrova, RK Ruseva, ... Journal of Clinical Oncology 41 (16_suppl), e24184-e24184, 2023 | | 2023 |
| PI3KCA mutation prevalence and outcome among patients with metastatic breast cancer in Bulgaria treated with first-line endocrine therapy. R Gencheva, S Hadjidekova, M Petrova, D Krustev, P Kraleva, ... Journal of Clinical Oncology 41 (16_suppl), e13005-e13005, 2023 | | 2023 |
| P-216 Serum levels of HMGB1 might have a predictive role for neoadjuvant radiotherapy combined with chemotherapy in rectal cancer patients T Radeva-Petkova, E Encheva, G Mihaylova, D Palamudova, S Bilyukova, ... Annals of Oncology 33, S326, 2022 | | 2022 |
| Impact of travel burden on overall survival in patients with lung cancer. DS Stoyanov, I Tonev, E Dimitrova, T Panayotova, R Manev, I Donev, ... Journal of Clinical Oncology 40 (16_suppl), 6522-6522, 2022 | | 2022 |
| Key Apoptosis Signaling Pathways In Malignant Diseases T Panayotova, D Stoyanov, R Manev, M Maneva, B Stefanova, ... Varna Medical Forum 10 (3), 9-13, 2021 | | 2021 |
| High neutrophil to lymphocyte ratio as a predictor for hyperprogressive disease in patients with metastatic non-small cell lung cancer treated with pembrolizumab as a second line. M Petrova, M Eneva, JI Arabadjiev, NV Conev, E Dimitrova, KD Koynov, ... Journal of Clinical Oncology 38 (15_suppl), e21546-e21546, 2020 | | 2020 |
| Dynamic of time estimation and its relation with levels of distress. NV Conev, M Ivanova, E Dimitrova, A Yanchev, I Donev Journal of Clinical Oncology 38 (15_suppl), e19091-e19091, 2020 | | 2020 |
